Archives     Advertise     Editorial Calendar      Advertiser Index     Subscribe     Contact Us    


Heart Monitor


 

Nashville hospitals are bringing the latest in cardiac care to Middle Tennessee. Below is a brief roundup of some of the recent news of note.


Mark Your Calendar

TriStar Health's Annual Cardiovascular Symposium is set for March 2, 2018 at the Music City Center downtown Nashville. The event takes place from 8 am - 4 pm. Attendees will learn about the latest advancements in cardiac care including heart failure, electrophysiology, cardiogenic shock, structural heart disease, cardiovascular surgery and more. Register online at: https://tristarhealth.com/medical-professionals/cme-programs/cardiovascular-symposium.dot.


Cardiology Mile Markers at Saint Thomas

It's a good time for cardiology at Saint Thomas Health, where their heart transplant program re-launched in 2016 following a hiatus. The program also is participating in more than 15 clinical trials related to cardiovascular health and operates a thriving aortic program.

Cardiologists at Saint Thomas Heart are now implanting the Full MagLev HeartMate 3 Left Ventricular Assist System. The HeartMate 3 LVAD system provides a new option for physicians managing advanced heart failure patients in need of short-term hemodynamic support (bridge-to-transplant or bridge-to-myocardial recovery). The HeartMate 3 also provides patients living with their device new benefits that embody the evolution of LVAD therapy.

It is the first device to receive FDA approval that is fully magnetically levitated, meaning the blood-pumping rotor has no bearings and is floating in a magnetic field. This makes the device more resistant to heat generation and thrombosis due to the design. Its predecessor, The Heartmate II, was the first continuous flow LVAD that commercially approved and is the device that made long term mechanical support a reality. Both Saint Thomas and Vanderbilt participated in the clinical trials to evaluate the safety and efficacy of HeartMate 3.


TriStar Offers New Cardio Options

Staying a beat ahead, TriStar Centennial Medical Center recently completed Middle Tennessee's first procedure utilizing the Tryton Side Branch Stent to treat a coronary bifurcation lesion involving a large side branch 2.5 mm or greater. The procedure was performed at TriStar Centennial Heart and Vascular Center led by Paul Myers, MD, in collaboration with Jeffrey Webber, MD, interventional cardiologists with Centennial Heart.

"TriStar Centennial is a national leader in cardiovascular care, utilizing the latest heart stent technology to treat high-risk cases of coronary artery disease," Myers said. "This innovative and comprehensive approach allows us to treat patients with complex and high-risk blockages that involve arteries with important larger branches off the main heart artery."

TriStar Hendersonville also recently introduced the Tryton Side Branch Stent procedure to its comprehensive list of cardiac disease treatment options.

In Smyrna, TriStar StoneCrest introduced CardioMEMS, which is the first and only FDA-approved heart failure monitoring system proven to significantly reduce heart failure hospital admissions and improve quality of life


Vanderbilt Continues Cardiology Expansions

From electrophysiology to advanced treatment for valvular disease, Vanderbilt University Medical Center (VUMC) is expanding its cardiology services and medical staff to reflect the latest treatments and research available.

Heart Transplant Program


Dr. Daniel Munoz

VUMC was recently recognized as the second busiest heart transplant program in the nation, falling just behind Cedars-Sinai Medical Center in Los Angeles. "We're continuing our positive evolution on campus as a world leader in heart transplant surgery," said cardiologist Daniel Munoz, MD, MPA, assistant professor and medical director for quality in the Division of Cardiology at Vanderbilt.

In 2017, 82 adult hearts were transplanted at Vanderbilt, with survival rates higher than the national average. "Our volume has grown tremendously in part to our leadership and the outstanding clinicians we've been able to recruit, but we're especially proud of the quality of our services and the chance to care for the most medically complicated cases," Munoz said.

Arrhythmia Services

VUMC is also taking its arrhythmia program to the next level with recruitment of internationally recognized electrophysiology cardiologists. Recent newcomers include William Stevenson, MD, and Gregory Michaud, MD, who serves as director of Arrhythmia/Electrophysiology in the Department of Medicine. Both specialists were recruited from Brigham and Women's Hospital at Harvard Medical School. "This is an already great program positioned to become a preeminent program thanks to Dr. Michaud's leadership," Munoz said. "One of the key challenges in ablation of atrial fibrillation is that not all procedures are equally successful, so it's really important to continue to understand best techniques to makes ablation as successful as possible."

Valvular Disease

Another area of focus for Vanderbilt is the treatment of valvular heart disease. "We're increasing the number of technological options for treatment of heart disease," Munoz noted. "Open-heart surgery remains the best option for certain patients; but over the past decade, catheter-based treatment of valve disease has emerged. We're trying to understand which patients benefit the most from these technologies and create a partnership between clinical services and researchers to understand not just how to do something but the best way to do it for the benefit of as many patients as possible."

Research

Vanderbilt has also continued to be on the leading edge of clinical research, having received three Strategically Focused Research Network grants from the American Heart Association designed to focus on disease prevention, obesity and vascular disease.

WEB:

Centennial Heart

Vanderbilt Heart

Saint Thomas Heart

 
Share:

Related Articles:


Recent Articles

Ascension Saint Thomas Heart First in State, Region, Ascension to Offer Novel Medical Technique

On February 9, Ascension Saint Thomas Hospital West became the first Ascension hospital in the country and the only medical facility in Tennessee to offer intracoronary brachytherapy, a procedure that helps improve chest pain in patients with stents that have re-narrowed (sometimes called "collapsed") and reduces the chance of them narrowing again in the future.

Read More

Functional Seizures Associated with Stroke, Psychiatric Disorders in Electronic Health Records Study

In a large-scale study of electronic health records, Vanderbilt University Medical Center investigators have determined the prevalence of functional seizures and characterized comorbidities associated with them.

Read More

New survey shows minorities, children missing cancer screenings and vaccinations

52% of adults missing lifesaving screenings to prevent cancer are not rescheduling them

Read More

Sarah Cannon Cancer Institute at Swedish Medical Center Sheds New Light on Brain Tumors

Neurosurgery is a complex and intricate process, and it is important to continuously refine and seek innovative techniques to make it safer, gentler and more precise and effective.

Read More

Study Finds Recommended ICU Sedatives Equally Safe, Effective

Sedative medications used in intensive care are associated with increased delirium, which is in turn connected with higher medical costs and greater risk of death and ICU-related dementia.

Read More

Spectrum Solutions Collaborates with UCLA on Saliva-Based Next-Gen Sequencing (NGS) Liquid Biopsy Research for the Early Detection of Lung Cancer

Study to focus on using saliva in the analysis of cell-free circulating tumor DNA (ctDNA) to accurately and non-invasively detect non-small cell lung cancer (NSCLC).

Read More

DRUG COMPANIES URGED TO PROVIDE DISCOUNTS TO 340B COMMUNITY PHARMACIES

Yesterday, counsel for the American Hospital Association and the five other national groups and three individual hospital systems that sued the Department of Health and Human Services (HHS) over its failure to halt drug company actions that undermine the 340B drug pricing program sent letters demanding that the offending drug companies immediately halt their illegal activities.

Read More

Study Shows Drastic Increases in Opioid-Affected Births

The rate of mothers who had an opioid-related diagnosis when delivering their baby increased by 131% from 2010-2017, as the incidence of babies diagnosed with drug withdrawal, known as neonatal abstinence syndrome (NAS), increased by 82% nationally during that same time period.

Read More

Case Management: Enhancing Revenue, Care Transitions and Patient Outcomes throughout the Hospital System

The importance of hospital and health system case management has grown exponentially over the past 10 years and is now getting attention from leaders throughout the healthcare industry.

Read More

TennCare Block Grant Waiver Approved

More than a year after submitting Amendment 42 to the Centers for Medicare and Medicaid Services (CMS) requesting a waiver to increase flexibility in the administration of the state's Medicaid program, Tennessee has received an affirmative nod to move forward.

Read More

Email Print
 
 

 

 


Tags:
CardioMEMS, Centennial Heart, Daniel Munoz MD, Gregory Michaud MD, Heart Transplants Nashville, HeartMate 3, Saint Thomas Health, TriStar Health, Tryton Stent, Vanderbilt Heart, VUMC, William Stevenson MD
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: